These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36137914)

  • 21. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
    van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
    J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
    [No Abstract]   [Full Text] [Related]  

  • 22. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
    Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
    Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
    Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in organ preserving strategies in rectal cancer patients.
    Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
    Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
    Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominoperineal resection for rectal cancer at a specialty center.
    Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
    Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective analysis of patient outcome following treatment of T3 rectal cancer with neo-adjuvant chemoradiotherapy and transanal excision.
    Kennelly RP; Heeney A; White A; Fennelly D; Sheahan K; Hyland JM; O'Connell PR; Winter DC
    Int J Colorectal Dis; 2012 Jun; 27(6):759-64. PubMed ID: 22173716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Impact of Ventral Versus Dorsal Tumor Location After Total Mesorectal Excision of Rectal Cancer.
    Franz C; Lang HM; Ghamarnejad O; Khajeh E; Mehrabi A; Ulrich A; Schneider M; Büchler MW; Kulu Y
    Ann Surg Oncol; 2020 Feb; 27(2):430-438. PubMed ID: 31549320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal.
    Peltrini R; Sacco M; Luglio G; Bucci L
    Updates Surg; 2020 Mar; 72(1):29-37. PubMed ID: 31621033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
    Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
    Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal cancer.
    McCourt M; Armitage J; Monson JR
    Surgeon; 2009 Jun; 7(3):162-9. PubMed ID: 19580180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer.
    Sclafani F; Cunningham D
    Future Oncol; 2014 Nov; 10(14):2243-57. PubMed ID: 25471037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation.
    Caricato M; Borzomati D; Ausania F; Tonini G; Rabitti C; Valeri S; Trodella L; Ripetti V; Coppola R
    Surg Endosc; 2006 Aug; 20(8):1203-7. PubMed ID: 16703429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.